Published in
Elsevier, The Lancet Oncology, 6(17), p. 811-821
DOI: 10.1016/s1470-2045(16)00106-6
Links
Tools
Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial
Journal article published in 2016 by
Ian E. Krop,
Ingrid A. Mayer,
Vinod Ganju,
Maura Dickler,
Stephen Johnston,
Serafin Morales 
,
Denise A. Yardley,
Bohuslav Melichar,
Andres Forero-Torres,
Soo Chin Lee,
Richard de Boer,
Katarina Petrakova,
Susanne Vallentin,
Edith A. Perez,
Martine Piccart
and other authors.
,
Denise A. Yardley,
Bohuslav Melichar,
Andres Forero-Torres,
Soo Chin Lee,
Richard de Boer,
Katarina Petrakova,
Susanne Vallentin,
Edith A. Perez,
Martine Piccart
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 